The OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Moderna reported better-than-expected 1Q24 revenue of $167 million and its pipeline looks promising. Read my earnings ...
The drugmaker expects to have its vaccine for respiratory syncytial virus, or RSV, approved in the US this month. He speaks on "Bloomberg Surveillance." Vanishing Acts: 20 Hollywood Stars Who Faded ...
The U.S. Food and Drug Administration on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi to include the treatment of adults with a type of blood cancer that ...
A man with a suspended license joined his court Zoom call while driving, astonishing the judge and his legal team.